20
Participants
Start Date
April 30, 2005
Primary Completion Date
June 30, 2009
Study Completion Date
September 30, 2010
aldesleukin
The IL-2 is given as a 15-minute infusion through an intravenous catheter (I.V.), a small plastic tube that is put into your vein for the time you are receiving the study treatment. IL-2 is given through the I.V. once every 8 hours for 5 days (days 1-5). A second 5 day cycle of IL-2 will begin on the 15th day (days 15-19). This is one complete cycle (days 1-19) of IL-2 treatment
denileukin diftitox
Denileukin diftitox will be administered once daily as a 15 to 60 minute infusion for 3 consecutive days.
Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago
National Cancer Institute (NCI)
NIH
Northwestern University
OTHER